跳至主要内容
临床试验/ACTRN12620001345976
ACTRN12620001345976尚未招募未知

Feasibility trial of a pharmacist-led, personalised intervention targeting the incidence of reliever reliance and overuse in individuals with asthma.

Dr Amy Chan0 个研究点目标入组 120 人开始时间: 2020年12月14日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Educational / counselling / training
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Individuals presenting to one of the two enrolled community pharmacies will be eligible to participate in the study if they meet the following eligibility criteria:
  • -Aged 18 years or over
  • -Prescribed a short acting beta agonist (SABA) as a ‘reliever’ for their asthma symptoms.

排除标准

  • Individuals will not be eligible to participate if they are using a SABA for a reason other than asthma (e.g. viral respiratory infection, exercise-induced asthma), do not manage their own medicines or anticipate changes to their medicines within the next 90 days (i.e. are following a step up/down medication management approach).

研究者

发起方
Dr Amy Chan

相似试验